Alzheimer's cure may be a matter of size

August 22, 2012, University of Queensland

(Medical Xpress) -- Size really does matter according to scientists looking for ways to cure Alzheimer's disease.

Research conducted by scientists at the Queensland Brain Institute (QBI) at The University of Queensland (UQ) and Harvard University, has led to the discovery that treatment for Alzheimer's disease may lie in modifying the length of subcellular structures in the brain responsible for metabolising energy, .

The study found in cases where the mitochondria were abnormally long, they had a inducing .

Director, Centre for Ageing Research (CADR) at QBI and co-author of the paper, Professor Jürgen Götz, said:

“Alzheimer's disease belongs to a group of neurodegenerative diseases termed ‘tauopathies', charaterised by clumps of the protein tau inside neurons.

“In instances where neurons express toxic levels of human tau, the mitochondria are elongated.

“All cells rely on mitochondria for energy metabolism, and neurons in particular, so controlling the length of these subcellular structures is very important for brain function.”

The research provides novel targets for therapeutic intervention.

“Treatments currently available for these diseases have at most modest effects, in part due to our limited understanding of how Alzheimer's disease starts and progresses,” Professor Götz said.

The good news is, genetic and drug interventions aimed at reducing mitochondrial length reverse the toxic effects of tau, and can now get underway.

“An aspect of mitochondrial regulation that is being increasingly appreciated are changes in size and shape of the organelle, through a process termed 'mitochondrial dynamics',” Professor Götz said.

Alzheimer's disease affects almost 280,000 Australians. This number grows by 1,600 each week and is expected to reach over 1 million people by 2050.

Alzheimer's disease

• Dementia is a term used for a range of conditions characterised by impairment of brain functions including language, memory, perception, personality and cognitive skills.
• The most common form of dementia is Alzheimer's disease, accounting for around 70 per cent of all cases.
• Conditions associated with dementia are typically progressive, degenerative and irreversible as there is symptomatic treatment but currently no cure.
• There are almost 280,000 Australians currently living with dementia. Each week, there are 1,600 new cases of dementia in Australia. This is expected to grow to over 1 million people by 2050 .
• By the 2060s, spending on dementia is set to outstrip that of any other health condition. It is projected to be $83 billion (in 2006-07 dollars), and will represent around 11 per cent of the entire health and residential aged care sector spending.
• Dementia is currently the third leading cause of death in Australia, after heart disease and stroke, with one in four people over the age of 85 suffering from dementia.
• Between 2000 and 2008, deaths attributed to Alzheimer's disease increased 66 per cent, while those attributed to the number one cause of death, heart disease, decreased 13 per cent (www.alz.org/downloads/Facts_Figures_2012.pdf).
• A legitimate research breakthrough that could delay the onset of dementia by five years could mean 35.2 per cent fewer cases by 2020 (cumulative savings of $13.5 billion) and 48.5 per cent fewer cases in 2040 (saving $67.5 billion) .
• Increasing research funding to $49 million per annum could generate a cure by 2040 and save the Australian economy $4 trillion in future health costs.

Explore further: Musical study challenges long-held view of left brain-right brain split

More information: From the paper ‘Tau promotes neurodegeneration via DRP1 mislocalization in vivo' for publication in Neuron, August 23, 2012 (print edition)

Related Stories

Musical study challenges long-held view of left brain-right brain split

June 4, 2012
(Medical Xpress) -- Ever been stuck in traffic when a feel-good song comes on the radio and suddenly your mood lightens?

Alzheimer's vaccine cures memory of mice

December 9, 2011
(Medical Xpress) -- A vaccine that slows the progression of Alzheimer's disease and other types of dementia has been developed by researchers at the University of Sydney's Brain and Mind Research Institute (BMRI).

Dementia cases to double by 2030: WHO

April 11, 2012
The number of people with dementia is expected to almost double to 65.7 million by 2030 as the world population ages, according to a World Health Organisation report published Wednesday.

Recommended for you

Rocky start for Alzheimer's drug research in 2018

January 19, 2018
The year 2018, barely underway, has already dealt a series of disheartening blows to the quest for an Alzheimer's cure.

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.